BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.
about
The sweet trap in tumors: aerobic glycolysis and potential targets for therapyC10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy.Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.Golgi apparatus dis- and reorganizations studied with the aid of 2-deoxy-D-glucose and visualized by 3D-electron tomography.Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma.Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance.The tubulin inhibitor MG-2477 induces autophagy-regulated cell death, ROS accumulation and activation of FOXO3 in neuroblastomaSelective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate.Mitochondrial survivin - an Achilles' heel in cancer chemoresistance.FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance.Very long-/ and long Chain-3-Hydroxy Acyl CoA Dehydrogenase Deficiency correlates with deregulation of the mitochondrial fusion/fission machinery.Cancer Chemoprevention and Piperine: Molecular Mechanisms and Therapeutic Opportunities.
P2860
Q26766079-DC75F48F-221D-456C-AE65-FCAAC3AAB230Q33730108-6EC40AF5-5603-4624-AC11-0F5819C474F2Q36481398-91326EE3-F5DF-40CC-984A-B3E892D76470Q37712748-0473ACED-F267-4147-A2D4-A50EA28BDD3BQ37718408-D0EC7C62-F6F0-41EE-97C4-3F5D4339F4A6Q38705079-9FEA4F52-D1D1-4C15-9556-5310CFC79BBCQ38741378-6E7F9F1B-019B-4D69-9932-F82941837353Q38834089-D1551913-36C3-4260-A08F-B53B015BC19BQ41520294-72864DB4-1B8D-4844-A4E7-29F6417DE9A0Q42730045-1A60F5FE-85A9-4A97-84E4-8661E2CA2DE2Q43816387-56442C77-23EE-4506-98DB-E7C92218F669Q47235034-CF689363-89D0-4A2B-8E7C-6C3B8DD42F60Q49830952-267C6673-4051-4920-98A1-BB61620BE9B0Q50333246-403FF693-BA3F-4349-BEDC-2EC31C05385E
P2860
BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.
@en
type
label
BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.
@en
prefLabel
BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.
@en
P2860
P356
P1433
P1476
BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma
@en
P2093
U Kiechl-Kohlendorfer
P2860
P2888
P304
P356
10.1038/ONC.2015.264
P407
P577
2015-07-06T00:00:00Z
P6179
1037467863